US Patent Issued to Nacuity Pharmaceuticals, The Johns Hopkins University on Nov. 18 for "Treatment of retinitis pigmentosa with n-acetylcysteine amide" (Maryland, Texas Inventors)

ALEXANDRIA, Va., Nov. 18 -- United States Patent no. 12,472,157, issued on Nov. 18, was assigned to Nacuity Pharmaceuticals Inc. (Fort Worth, Texas) and The Johns Hopkins University (Baltimore).

"Treatment of retinitis pigmentosa with n-acetylcysteine amide" was invented by Peter A. Campochiaro (Baltimore) and Daniel Hartman (Fort Worth, Texas).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention includes a method for the treatment of retinitis pigmentosa in a human that comprises administering to the human a therapeutically effective amount of N-acetylcysteine amide (NACA). In accordance with an embodiment, the present invention provides a method for the treatment of retinitis pigmentosa in a...